1242 related articles for article (PubMed ID: 17303592)
1. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
[TBL] [Abstract][Full Text] [Related]
3. Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis.
Caparros-Lefebvre D; Lees AJ
Mov Disord; 2005 Aug; 20 Suppl 12():S114-8. PubMed ID: 16092100
[TBL] [Abstract][Full Text] [Related]
4. Atypical parkinsonism in the Caribbean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacin.
Lannuzel A; Ruberg M; Michel PP
Mov Disord; 2008 Nov; 23(15):2122-8. PubMed ID: 18816693
[TBL] [Abstract][Full Text] [Related]
5. Predominant cortical dysfunction in Guadeloupean parkinsonism.
Apartis E; Gaymard B; Verhaeghe S; Roze E; Vidailhet M; Lannuzel A
Brain; 2008 Oct; 131(Pt 10):2701-9. PubMed ID: 18941145
[TBL] [Abstract][Full Text] [Related]
6. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group.
Caparros-Lefebvre D; Elbaz A
Lancet; 1999 Jul; 354(9175):281-6. PubMed ID: 10440304
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.
Linder J; Stenlund H; Forsgren L
Mov Disord; 2010 Feb; 25(3):341-8. PubMed ID: 20108376
[TBL] [Abstract][Full Text] [Related]
8. Caribbean parkinsonism and other atypical parkinsonian disorders.
Tolosa E; Calandrella D; Gallardo M
Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S19-26. PubMed ID: 15109583
[TBL] [Abstract][Full Text] [Related]
9. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
10. Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.
Caparros-Lefebvre D; Sergeant N; Lees A; Camuzat A; Daniel S; Lannuzel A; Brice A; Tolosa E; Delacourte A; Duyckaerts C
Brain; 2002 Apr; 125(Pt 4):801-11. PubMed ID: 11912113
[TBL] [Abstract][Full Text] [Related]
11. A differential diagnosis of Parkinsonism.
Weiner WJ
Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
[TBL] [Abstract][Full Text] [Related]
13. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism.
Steele JC; Caparros-Lefebvre D; Lees AJ; Sacks OW
Parkinsonism Relat Disord; 2002 Oct; 9(1):39-54. PubMed ID: 12217621
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
15. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
[TBL] [Abstract][Full Text] [Related]
16. Parkinsonism plus syndrome--a review.
Mitra K; Gangopadhaya PK; Das SK
Neurol India; 2003 Jun; 51(2):183-8. PubMed ID: 14570999
[TBL] [Abstract][Full Text] [Related]
17. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
Williams DR; Lees AJ
Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
[TBL] [Abstract][Full Text] [Related]
18. MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study.
Morelli M; Arabia G; Novellino F; Salsone M; Giofrè L; Condino F; Messina D; Quattrone A
Neurology; 2011 Sep; 77(11):1042-7. PubMed ID: 21832222
[TBL] [Abstract][Full Text] [Related]
19. [A 65-year-old man with Parkinsonism, gaze palsy, and dementia].
Mizuno Y; Yokochi F; Ohta S; Mori H; Takubo H
No To Shinkei; 1996 Apr; 48(4):381-93. PubMed ID: 8679336
[TBL] [Abstract][Full Text] [Related]
20. The clinical spectrum of freezing of gait in atypical parkinsonism.
Factor SA
Mov Disord; 2008; 23 Suppl 2():S431-8. PubMed ID: 18668624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
